Procter & GamblePGCOMMENTSep 17, 2015Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
60% of revenues come from outside of North America. That means the currency is going to be a headwind against them. Trading at about 18X forward earnings, with probably a mid-single digit 6%-7% long-term EPS growth rate. That puts it at a pretty high clip in terms of valuation. Pays a nice dividend of 3.75%.